Genpharmasec Ltd — Board Meeting, 21-05-2025: Board Meeting

Genpharmasec Limited has announced a board meeting on 21 May 2025, where it approved the audited standalone and consolidated financial results for the quarter and financial year ended 31 March 2025. The statutory auditors issued an unmodified opinion on the results. Key appointments include M/s. Abhishek M Agrawal & Co. as Internal Auditor for FY 2025-26, and M/s. Jaymin Modi & Co. as Secretarial Auditors for five years, subject to shareholder approval. The company’s standalone revenue was Rs. 33.0 Cr, with a profit after tax of Rs. 2.47 Cr, reflecting steady operational performance. It also completed a major share allotment through a rights issue and expanded via a wholly owned subsidiary, Clinigenome India Pvt Ltd, while continuing its investment in Derren Healthcare Pvt Ltd pending controlling interest.